Tudor Investment Corp’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Buy
+33,540
New +$3.06M ﹤0.01% 1792
2025
Q4
Sell
-68,654
Closed -$9.42M 4115
2025
Q3
$7.4M Buy
+68,654
New +$7.48M 0.01% 939
2025
Q2
Sell
-7,921
Closed -$622K 3824
2025
Q1
$702K Sell
7,921
-93,889
-92% -$8.15M ﹤0.01% 2065
2024
Q4
$7.83M Buy
101,810
+41,084
+68% +$2.87M 0.03% 471
2024
Q3
$2.58M Sell
60,726
-30,761
-34% -$1.04M 0.01% 1057
2024
Q2
$2.39M Buy
+91,487
New +$1.73M 0.01% 975
2022
Q2
Sell
-307
Closed -$31K 2559
2022
Q1
$31K Sell
307
-672
-69% -$74.7K ﹤0.01% 1887
2021
Q4
$144K Buy
979
+556
+131% +$124K ﹤0.01% 2209
2021
Q3
$106K Buy
+423
New +$145K ﹤0.01% 2359

Other funds holding WGS

Tudor Investment Corp's WGS Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in GeneDx Holdings (WGS) in Q1 2026: 33,540 shares worth $2.15M. The stake represents ﹤0.01% of the portfolio and ranks #1792 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in WGS as recently as Q3 2025.

Tudor Investment Corp first reported a position in WGS in Q3 2021 and has held it in 9 quarters since. The position peaked at $7.83M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Tudor Investment Corp held 33,540 shares of GeneDx Holdings worth $2.15M as of Q1 2026.
  • GeneDx Holdings was a new Tudor Investment Corp position in Q1 2026.
  • GeneDx Holdings made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1792 holding.
  • Tudor Investment Corp first reported a position in GeneDx Holdings in Q3 2021 and has held it in 9 quarters since.
  • Tudor Investment Corp's GeneDx Holdings position peaked at $7.83M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.